Toward precision medicine in Parkinson's disease.
暂无分享,去创建一个
Feng-Tao Liu | Jian Wang | Boyd Anderson | Ke Yang | Wei-Xi Xiong | Jian Wang | Ye Wang | Lu-Lu Bu | Ke Yang | Wei-Xi Xiong | Lu-Lu Bu | Boyd Anderson | Ye Wang | Feng-tao Liu | Feng-tao Liu
[1] E. Mayer,et al. Gut/brain axis and the microbiota. , 2015, The Journal of clinical investigation.
[2] Christian Duval,et al. Are quantitative and clinical measures of bradykinesia related in advanced Parkinson's disease? , 2013, Journal of Neuroscience Methods.
[3] Eric S. Lander,et al. Cutting the Gordian helix--regulating genomic testing in the era of precision medicine. , 2015, The New England journal of medicine.
[4] F Lhermitte,et al. Does long‐term aggravation of Parkinson's disease result from nondopaminergic lesions? , 1987, Neurology.
[5] I. McKeith,et al. Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[6] M. Neunlist,et al. Activity‐dependent secretion of alpha‐synuclein by enteric neurons , 2013, Journal of neurochemistry.
[7] D. Klonoff. Precision Medicine for Managing Diabetes , 2015, Journal of diabetes science and technology.
[8] G. Deuschl,et al. MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[9] John F. Cryan,et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve , 2011, Proceedings of the National Academy of Sciences.
[10] Jeffrey M. Hausdorff,et al. Wearable Assistant for Parkinson’s Disease Patients With the Freezing of Gait Symptom , 2010, IEEE Transactions on Information Technology in Biomedicine.
[11] Jeffrey M. Hausdorff,et al. Identifying axial and cognitive correlates in patients with Parkinson’s disease motor subtype using the instrumented Timed Up and Go , 2013, Experimental Brain Research.
[12] Grant D. Huang,et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. , 2010, The New England journal of medicine.
[13] L. Lannfelt,et al. Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders. , 2014, Immunotherapy.
[14] F. Horak,et al. iTUG, a Sensitive and Reliable Measure of Mobility , 2010, IEEE Transactions on Neural Systems and Rehabilitation Engineering.
[15] R. Dobbs,et al. Peripheral aetiopathogenic drivers and mediators of Parkinson’s disease and co-morbidities: role of gastrointestinal microbiota , 2015, Journal of NeuroVirology.
[16] B. Najafi,et al. Precision Medicine: A Wider Definition , 2015, Journal of the American Geriatrics Society.
[17] P. Damier,et al. Colonic Biopsies to Assess the Neuropathology of Parkinson's Disease and Its Relationship with Symptoms , 2010, PloS one.
[18] H. Forssberg,et al. Normal gut microbiota modulates brain development and behavior , 2011, Proceedings of the National Academy of Sciences.
[19] K. McCoy,et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. , 2011, Gastroenterology.
[20] G. Petsko,et al. Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations , 2015, The Lancet Neurology.
[21] Michael J. Frank,et al. Hold Your Horses: Impulsivity, Deep Brain Stimulation, and Medication in Parkinsonism , 2007, Science.
[22] Ned Jenkinson,et al. Pedunculopontine Nucleus Stimulation Improves Gait Freezing in Parkinson Disease , 2011, Neurosurgery.
[23] E. Pekkonen,et al. Gut microbiota are related to Parkinson's disease and clinical phenotype , 2015, Movement disorders : official journal of the Movement Disorder Society.
[24] P. Forsythe,et al. Voices from within: gut microbes and the CNS , 2012, Cellular and Molecular Life Sciences.
[25] H. Braak,et al. Parkinson's disease: a dual‐hit hypothesis , 2007, Neuropathology and applied neurobiology.
[26] R. Mach,et al. Binding of the Radioligand SIL23 to α-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging Agent , 2013, PloS one.
[27] Refet Firat Yazicioglu,et al. Closing the loop for deep brain stimulation implants enables personalized healthcare for Parkinson's disease patients , 2011, 2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[28] S. Haber,et al. Closed-Loop Deep Brain Stimulation Is Superior in Ameliorating Parkinsonism , 2011, Neuron.
[29] A. Probst,et al. α‐Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects , 2006, Neuropathology and applied neurobiology.
[30] H. Braak,et al. Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology , 2006, Neuroscience Letters.
[31] P. Bonato,et al. Using Wearable Sensors to Enhance DBS Parameter Adjustment for Parkinson's Disease Patients Through Measures of Motor Response , 2006, 2006 3rd IEEE/EMBS International Summer School on Medical Devices and Biosensors.
[32] Thomas O. Mera,et al. Quantitative assessment of levodopa-induced dyskinesia using automated motion sensing technology , 2012, 2012 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[33] Hayriye Cagnan,et al. Bilateral adaptive deep brain stimulation is effective in Parkinson's disease , 2015, Journal of Neurology, Neurosurgery & Psychiatry.
[34] Thomas O. Mera,et al. Feasibility of home-based automated Parkinson's disease motor assessment , 2012, Journal of Neuroscience Methods.
[35] A. Brice,et al. What genetics tells us about the causes and mechanisms of Parkinson's disease. , 2011, Physiological reviews.
[36] Lorenzo Chiari,et al. ISway: a sensitive, valid and reliable measure of postural control , 2012, Journal of NeuroEngineering and Rehabilitation.
[37] María Teresa Arredondo,et al. Gait assessment in Parkinson's disease patients through a network of wearable accelerometers in unsupervised environments , 2011, 2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[38] K. Shannon,et al. Is alpha‐synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases , 2012, Movement disorders : official journal of the Movement Disorder Society.
[39] P. Brown,et al. Adaptive Deep Brain Stimulation In Advanced Parkinson Disease , 2013, Annals of neurology.
[40] Clement Hamani,et al. Unilateral pedunculopontine stimulation improves falls in Parkinson's disease. , 2010, Brain : a journal of neurology.
[41] Erika Check Hayden,et al. Technology: The $1,000 genome , 2014, Nature.
[42] J. Giuffrida,et al. Objective motion sensor assessment highly correlated with scores of global levodopa-induced dyskinesia in Parkinson's disease. , 2013, Journal of Parkinson's disease.
[43] Ron Alterman,et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial , 2012, The Lancet Neurology.
[44] Joseph M Mahoney,et al. Both coordination and symmetry of arm swing are reduced in Parkinson's disease. , 2012, Gait & posture.
[45] Marcelo A. Wood,et al. Automated scoring of fear-related behavior using EthoVision software , 2009, Journal of Neuroscience Methods.
[46] Y. Agid,et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. , 2002, Brain : a journal of neurology.
[47] Vincenzo Bonifati,et al. The genetics of Parkinson's disease: Progress and therapeutic implications , 2013, Movement disorders : official journal of the Movement Disorder Society.
[48] C. Duyckaerts,et al. The second brain and Parkinson’s disease , 2009, The European journal of neuroscience.
[49] Jeffrey M. Hausdorff,et al. Objective Assessment of Fall Risk in Parkinson's Disease Using a Body-Fixed Sensor Worn for 3 Days , 2014, PloS one.
[50] S E Ide,et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.
[51] M. Helwig,et al. Caudo-rostral brain spreading of α-synuclein through vagal connections , 2013, EMBO molecular medicine.
[52] C. Ballard,et al. Neuroimaging for Lewy body disease: Is the in vivo molecular imaging of α-synuclein neuropathology required and feasible? , 2010, Brain Research Reviews.
[53] A. Benabid,et al. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. , 1987, Applied neurophysiology.
[54] E. Benarroch,et al. Neural control of the gastrointestinal tract: Implications for Parkinson disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[55] B. Naliboff,et al. Consumption of fermented milk product with probiotic modulates brain activity. , 2013, Gastroenterology.
[56] J. Cummings,et al. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. , 2011, Brain : a journal of neurology.
[57] Hiroshi Mitoma,et al. 24-hour recording of parkinsonian gait using a portable gait rhythmogram. , 2010, Internal medicine.
[58] T. Dinan,et al. The impact of microbiota on brain and behavior: mechanisms & therapeutic potential. , 2014, Advances in experimental medicine and biology.
[59] J. Obeso,et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. , 2005, Brain : a journal of neurology.
[60] Hayat Belaid,et al. PPNa-DBS for gait and balance disorders in Parkinson’s disease: a double-blind, randomised study , 2015, Journal of Neurology.
[61] Ali Keshavarzian,et al. Colonic bacterial composition in Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[62] Patrick T. Hickey,et al. Neuroimaging of Parkinson's disease: Expanding views , 2015, Neuroscience & Biobehavioral Reviews.
[63] A. Lang,et al. Parkinson's disease subtypes: lost in translation? , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[64] D. Devos,et al. Colonic inflammation in Parkinson's disease , 2013, Neurobiology of Disease.
[65] R. Mach,et al. Radiosynthesis and in Vivo Evaluation of Two PET Radioligands for Imaging α-Synuclein , 2014, Applied sciences.
[66] Elena Moro,et al. New targets for deep brain stimulation treatment of Parkinson’s disease , 2013, Expert review of neurotherapeutics.
[67] Jeffrey H. Kordower,et al. Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease , 2011, PloS one.
[68] E. Mayer,et al. Principles and clinical implications of the brain–gut–enteric microbiota axis , 2009, Nature Reviews Gastroenterology &Hepatology.
[69] N. Quinn,et al. “Atypical” atypical parkinsonism: New genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy—A diagnostic guide , 2013, Movement disorders : official journal of the Movement Disorder Society.
[70] Luca Palmerini,et al. Balance Testing With Inertial Sensors in Patients With Parkinson's Disease: Assessment of Motor Subtypes , 2014, IEEE Transactions on Neural Systems and Rehabilitation Engineering.
[71] Dimitrios I. Fotiadis,et al. An automated methodology for levodopa-induced dyskinesia: Assessment based on gyroscope and accelerometer signals , 2012, Artif. Intell. Medicine.
[72] F. Collins,et al. A new initiative on precision medicine. , 2015, The New England journal of medicine.
[73] D J Brooks,et al. Advances in imaging Parkinson's disease. , 1997, Current opinion in neurology.
[74] T. Dinan,et al. Mind-altering Microorganisms: the Impact of the Gut Microbiota on Brain and Behaviour , 2022 .
[75] Peter Brown,et al. Deep brain stimulation of the subthalamic nucleus: A two-edged sword , 2006, Current Biology.
[76] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[77] J. Bienenstock,et al. Psychoactive bacteria Lactobacillus rhamnosus (JB-1) elicits rapid frequency facilitation in vagal afferents. , 2013, American journal of physiology. Gastrointestinal and liver physiology.
[78] D. Longo,et al. Precision medicine--personalized, problematic, and promising. , 2015, The New England journal of medicine.
[79] M. Blaser. The microbiome revolution. , 2014, The Journal of clinical investigation.